Form 4 - Statement of changes in beneficial ownership of securities
22 Maggio 2024 - 1:11AM
Edgar (US Regulatory)
SEC Form 4
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0287 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
|
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
BlueLinx Holdings Inc.
[ BXC ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
3. Date of Earliest Transaction
(Month/Day/Year)
05/17/2024
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
|---|
| 1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
Amount |
(A) or (D) |
Price |
| Common Stock |
05/18/2024 |
|
M |
|
2,601
|
A |
|
7,530 |
D |
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Restricted Stock Units |
|
05/17/2024 |
|
A |
|
2,234 |
|
|
|
Common Stock |
2,234 |
$0
|
2,234 |
D |
|
| Restricted Stock Units |
|
05/18/2024 |
|
M |
|
|
2,601 |
|
|
Common Stock |
2,601 |
$0
|
0 |
D |
|
| Restricted Stock Units |
|
|
|
|
|
|
|
|
|
Common Stock |
21,334 |
|
21,334 |
I |
By grantor trust |
| Restricted Stock Units |
|
|
|
|
|
|
|
|
|
Common Stock |
9,485 |
|
9,485 |
I |
By grantor trust |
| Restricted Stock Units |
|
|
|
|
|
|
|
|
|
Common Stock |
15,108 |
|
15,108 |
I |
By grantor trust |
| Restricted Stock Units |
|
|
|
|
|
|
|
|
|
Common Stock |
22,253 |
|
22,253 |
I |
By grantor trust |
| Restricted Stock Units |
|
|
|
|
|
|
|
|
|
Common Stock |
10,294 |
|
10,294 |
I |
By grantor trust |
| Restricted Stock Units |
|
|
|
|
|
|
|
|
|
Common Stock |
14,754 |
|
14,754 |
I |
By grantor trust |
| Restricted Stock Units |
|
|
|
|
|
|
|
|
|
Common Stock |
9,090 |
|
9,090 |
I |
By grantor trust |
| Explanation of Responses: |
|
|
|
|
|
|
|
|
|
|
| Remarks: |
|
|
/s/ Christin Lumpkin, as attorney-in-fact for Kim S. Fennebresque |
05/21/2024 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 24
POWER OF ATTORNEY
Know
all by these presents that the undersigned hereby constitutes and appoints each of Tricia Kinney, Christin Lumpkin, and Brad Resler,
signing singly, the undersigned's true and lawful attorney-in-fact to:
| (1) | execute
for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or
director of BlueLinx Holdings Inc. (“Company”) and Forms 3, 4, and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as amended (“Exchange Act”),
and the rules thereunder; |
| (2) | do
and perform any and all acts for and on behalf of the undersigned which may be necessary
or desirable to complete and execute any such Form 3, 4, and/or 5, including any amendments
and supplements thereto, and file such form and all exhibits with the United States Securities
and Exchange Commission (“SEC”) and any stock exchange or similar authority,
including without limitation, the filing of a Form ID or any other documents necessary or
appropriate to enable the undersigned to file such Form 3, 4 and 5 electronically with the
SEC; and |
| (3) | take
any other action of any type whatsoever in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required
by or for, the undersigned, it being understood that the documents executed by such attorney-in-fact
on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such information and disclosure as such attorney-in-fact may approve in such
attorney-in-fact's discretion. |
The
undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever
required, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact,
in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with, or any liability for the failure to comply with, any provision of Section 16 of the Exchange Act.
This
Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect
to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
IN
WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the 29th day of February, 2024.
| |
/s/ Kim S. Fennebresque |
| |
Kim S. Fennebresque |
Exhibit 24
POWER OF ATTORNEY
Know
all by these presents that the undersigned hereby constitutes and appoints each of Tricia Kinney, Christin Lumpkin, and Brad Resler,
signing singly, the undersigned's true and lawful attorney-in-fact to:
| (1) | execute
for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or
director of BlueLinx Holdings Inc. (“Company”) and Forms 3, 4, and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as amended (“Exchange Act”),
and the rules thereunder; |
| (2) | do
and perform any and all acts for and on behalf of the undersigned which may be necessary
or desirable to complete and execute any such Form 3, 4, and/or 5, including any amendments
and supplements thereto, and file such form and all exhibits with the United States Securities
and Exchange Commission (“SEC”) and any stock exchange or similar authority,
including without limitation, the filing of a Form ID or any other documents necessary or
appropriate to enable the undersigned to file such Form 3, 4 and 5 electronically with the
SEC; and |
| (3) | take
any other action of any type whatsoever in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required
by or for, the undersigned, it being understood that the documents executed by such attorney-in-fact
on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such information and disclosure as such attorney-in-fact may approve in such
attorney-in-fact's discretion. |
The
undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever
required, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact,
in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with, or any liability for the failure to comply with, any provision of Section 16 of the Exchange Act.
This
Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect
to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
IN
WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the 29th day of February, 2024.
| |
/s/ Kim S. Fennebresque |
| |
Kim S. Fennebresque |
Grafico Azioni BlueLinx (NYSE:BXC)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni BlueLinx (NYSE:BXC)
Storico
Da Dic 2023 a Dic 2024
